Chiron Capital Management, LLC Biogen Inc. Transaction History
Chiron Capital Management, LLC
- $111 Million
- Q3 2024
A detailed history of Chiron Capital Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Chiron Capital Management, LLC holds 1,325 shares of BIIB stock, worth $219,671. This represents 0.23% of its overall portfolio holdings.
Number of Shares
1,325Holding current value
$219,671% of portfolio
0.23%Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,022Shares Held
126MCall Options Held
1.18MPut Options Held
1.36M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.77 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.7 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.41 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.22 Billion0.06% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$941 Million0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $23.9B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...